Cann Group Limited announced that Tony Di Pietro will act as joint Company Secretary with Steven Notaro, Head of Legal and Regulatory Affairs at Cann Group. . Having spent the past two decades at ASX-listed companies, Mr. Di Pietro boasts extensive experience as CFO/Company Secretary in the med-tech industry, with his last three roles at Sienna Cancer Diagnostics Limited (November 2014 - July 2020), INOVIQ Limited (July 2020 - November 2022) and Genetic Technologies Limited (November 2022 - present).

In his most recent role at Genetic Technologies, Mr. Di Pietro managed a capital raising of $5 million from US-based investors and was responsible for both US and Australian due diligence activities and compliance with both ASX/Corporations Act & NASDAQ/SEC regulations. Mr. Di Pietro's qualifications include: A Bachelor of Commerce (BCom),Accounting and Finance, from Swinburne University of Technology;Chartered Accountants (CA) accreditation (1989-2000); Graduate Diploma of Applied Corporate Governancefrom the Governance Institute of Australia(2012-2014); and Completed the Company Directors Course at the Australian Institute of Company Directors in 2018.